SomnoMed Ltd

RJV

Company Profile

  • Business description

    SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.

  • Contact

    20 Clarke Street
    Level 3
    Crows Nest
    SydneyNSW2065
    AUS

    T: +61 294670400

    https://www.somnomed.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2026

    Employees

    22

Stocks News & Analysis

stocks

Are there signs of an AI bubble in Nvidia’s earnings?

Our view after third-quarter results.
stocks

Picking dividend shares in 2026? Here’s where to look

A new report from Morningstar shows opportunities for income investors.
stocks

Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?

With outstanding long-term estimates, here’s what we think of Nvidia stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,834.0088.401.01%
CAC 407,981.0727.300.34%
DAX 4023,278.85115.930.50%
Dow JONES (US)45,795.95342.82-0.74%
FTSE 1009,527.6520.240.21%
HKSE25,835.574.920.02%
NASDAQ22,218.67345.56-1.53%
Nikkei 22549,823.941,286.242.65%
NZX 50 Index13,439.40112.500.84%
S&P 5006,567.2874.88-1.13%
S&P/ASX 2008,552.7084.701.00%
SSE Composite Index3,931.0515.69-0.40%

Market Movers